260 related articles for article (PubMed ID: 24342949)
81. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
Martens JH; Mandoli A; Simmer F; Wierenga BJ; Saeed S; Singh AA; Altucci L; Vellenga E; Stunnenberg HG
Blood; 2012 Nov; 120(19):4038-48. PubMed ID: 22983443
[TBL] [Abstract][Full Text] [Related]
82. Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes.
Taviaux S; Brunel V; Dupont M; Fernandez F; Ferraz C; Carbuccia N; Sainty D; Demaille J; Birg F; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 1999 Feb; 24(2):165-71. PubMed ID: 9885986
[TBL] [Abstract][Full Text] [Related]
83. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
84. The AML1/ETO fusion protein activates transcription of BCL-2.
Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
[TBL] [Abstract][Full Text] [Related]
85. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
[TBL] [Abstract][Full Text] [Related]
86. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.
Mannari D; Gascoyne D; Dunne J; Chaplin T; Young B
Leukemia; 2010 Apr; 24(4):891-4. PubMed ID: 20111069
[No Abstract] [Full Text] [Related]
87. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).
Zhang L; Li Q; Li W; Liu B; Wang Y; Lin D; Zhou C; Li C; Wang J; Mi Y
Int J Hematol; 2013 Jun; 97(6):786-92. PubMed ID: 23613269
[TBL] [Abstract][Full Text] [Related]
88. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
[TBL] [Abstract][Full Text] [Related]
89. Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO.
Roh SH; Kasembeli M; Galaz-Montoya JG; Trnka M; Lau WC; Burlingame A; Chiu W; Tweardy DJ
J Biol Chem; 2016 Feb; 291(9):4732-41. PubMed ID: 26706127
[TBL] [Abstract][Full Text] [Related]
90. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
91. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.
Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L
PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536
[TBL] [Abstract][Full Text] [Related]
92. Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells.
Liu X; Sun W; Wang L; Zhou B; Li P
Bull Cancer; 2023 Apr; 110(4):342-351. PubMed ID: 36863921
[TBL] [Abstract][Full Text] [Related]
93. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.
Heidenreich O; Krauter J; Riehle H; Hadwiger P; John M; Heil G; Vornlocher HP; Nordheim A
Blood; 2003 Apr; 101(8):3157-63. PubMed ID: 12480707
[TBL] [Abstract][Full Text] [Related]
94. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.
Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z
Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642
[TBL] [Abstract][Full Text] [Related]
95. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
96. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
Zhang Y; Strissel P; Strick R; Chen J; Nucifora G; Le Beau MM; Larson RA; Rowley JD
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3070-5. PubMed ID: 11867721
[TBL] [Abstract][Full Text] [Related]
97. Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Zhou L; Fu L; Lv N; Liu J; Li Y; Chen X; Xu Q; Chen G; Pang B; Wang L; Li Y; Zhang X; Yu L
Exp Mol Med; 2018 Apr; 50(4):1-8. PubMed ID: 29674693
[TBL] [Abstract][Full Text] [Related]
98. AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.
Barbetti V; Tusa I; Cipolleschi MG; Rovida E; Dello Sbarba P
Cell Death Dis; 2013 Mar; 4(3):e536. PubMed ID: 23492767
[TBL] [Abstract][Full Text] [Related]
99. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.
Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF
Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365
[TBL] [Abstract][Full Text] [Related]
100. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G; Rowley JD
Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
